Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Howard A Liebman"'
Publikováno v:
HemaSphere, Vol 7, p e1068344 (2023)
Externí odkaz:
https://doaj.org/article/4620083599bb4205a11534a8a363457a
Autor:
Eric Cheung, Howard A Liebman
Publikováno v:
Biologics: Targets & Therapy, Vol 2009, Iss default, Pp 57-62 (2009)
Eric Cheung, Howard A LiebmanJane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California-Keck School of Medicine, Los Angeles, CA, USAAbstract: Immune thrombocytopenia (ITP) is an acquired bleed
Externí odkaz:
https://doaj.org/article/8c27a3481c224548b27794267cd319dd
Autor:
Bruce Furie, Barbara C. Furie, Kenneth A. Bauer, Romaric Lacroix, Donna Neuberg, Howard A. Liebman, Jeffrey I. Zwicker
Supplementary Data from Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aad7e6012ac0ad4c3e2cd36979c9984
https://doi.org/10.1158/1078-0432.22440705
https://doi.org/10.1158/1078-0432.22440705
Autor:
Bruce Furie, Barbara C. Furie, Kenneth A. Bauer, Romaric Lacroix, Donna Neuberg, Howard A. Liebman, Jeffrey I. Zwicker
Purpose: Despite the strong association between malignant disease and thromboembolic disorders, the molecular and cellular basis of this relationship remains uncertain. We evaluated the hypothesis that tumor-derived tissue factorbearing microparticle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c634474010be5e2c11d7ef2fe4af70
https://doi.org/10.1158/1078-0432.c.6518001
https://doi.org/10.1158/1078-0432.c.6518001
Autor:
Vinod Pullarkat, David O. Beenhouwer, Jeffrey S. Wasser, Jenny M. Despotovic, Keith R. McCrae, Adam Cuker, Michele P. Lambert, Michael S. Broder, Roger M. Lyons, Sarah N Gibbs, Caroline Kruse, Rachael F. Grace, Howard A. Liebman, Irina Yermilov
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 69-80 (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Background Thrombopoietin receptor agonists (TPO-RAs) are used to treat primary immune thrombocytopenia (ITP). Some patients have discontinued treatment while maintaining a hemostatic platelet count. Objectives To develop expert consensus on when it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0369238422f3b2bd6937a37aae49a6
https://doaj.org/article/227a3e2d261045778633731119f64d14
https://doaj.org/article/227a3e2d261045778633731119f64d14
Autor:
Jean M. Connors, Alok A. Khorana, Rachel P. Rosovsky, Maria T. DeSancho, Howard A. Liebman, Jeffrey I. Zwicker
Publikováno v:
Oncologist
Venous and arterial thromboembolism are prevalent, highly burdensome, and associated with risk of worse outcomes for patients with cancer. Risk for venous thromboembolism (VTE) varies widely across specific cancer subpopulations. The ability to predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64508c719c02a43d88d7065e62ab619b
https://doi.org/10.1002/onco.13569
https://doi.org/10.1002/onco.13569
Autor:
Luanda Grazette, Arjun Mehta, Melody Hermel, Erika Jones, Saif Azam, Ilene C. Weitz, Annahita Sarcon, David J. Hermel, Howard A. Liebman, Jerold S. Shinbane
Publikováno v:
eJHaem. 1:44-50
Catastrophic antiphospholipid antibody syndrome (CAPS) is a rare form of antiphospholipid syndrome, an autoimmune condition characterized by vascular thromboses, pregnancy loss, and antiphospholipid (aPL) antibodies. Diagnosis of CAPS relies on throm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c67ef6972a979270e08f922dd20734f
https://doi.org/10.1002/jha2.71
https://doi.org/10.1002/jha2.71
Autor:
James B. Bussel, David J. Kuter, Alexandra Kruse, Andrew D. Leavitt, Douglas B. Cines, Howard A. Liebman, Jennifer DiRaimo, Terry Gernsheimer, Jecko Thachil, Caroline Kruse, Marina Beltrami Moreira, Adam Cuker, Craig M. Kessler, Michael D. Tarantino, Ashley Ray, Eun-Ju Lee, Hanny Al-Samkari, Adrian C. Newland, Alfred Ian Lee
Publikováno v:
Blood. 139(10)
Cases of de novo immune thrombocytopenia (ITP), including a fatality, following SARS-CoV-2 vaccination in previously healthy recipients led to studying its impact in preexisting ITP. In this study, 4 data sources were analyzed: the Vaccine Adverse Ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8afdd0bc4ca64e4aa142be313ac928f8
https://pubmed.ncbi.nlm.nih.gov/35267007
https://pubmed.ncbi.nlm.nih.gov/35267007
Autor:
Ilene C. Weitz, Hillel Bocian, Caroline I. Piatek, Casey O'Connell, Sandra Algaze, Howard A. Liebman
Publikováno v:
Acta Haematologica. 143:244-249
The combination of rituximab, cyclophosphamide, and dexamethasone (RCD) is highly effective in the treatment of warm autoimmune hemolytic anemia (WAIHA) associated with chronic lymphocytic leukemia (CLL). We treated a cohort of patients with relapsed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251ad9f258df649b0fe970179903c887
https://doi.org/10.1159/000501538
https://doi.org/10.1159/000501538
A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia
Autor:
Markus Peck-Radosavljevic, Roy Bentley, Howard A. Liebman, Akiyoshi Takami, Joanna Lorens, Anna Jakubowska, Zobair M. Younossi, Ryosuke Tateishi, Adrian Newland, Vanessa Taieb
Publikováno v:
Hematology. 24:679-719
Objective: Investigate globally, current treatment patterns, benefit-risk assessments, humanistic, societal and economic burden of platelet transfusion (PT). Methods: Publications from 1998 to June 27, 2018 were identified, based on databases searche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aebbbdbc453dca3e55e1cde70615935e
https://doi.org/10.1080/16078454.2019.1662200
https://doi.org/10.1080/16078454.2019.1662200